Sleep Medicine Reviews
Volume 7, Issue 2 , Pages 131-143 , April 2003

Sleep disturbances in dialysis patients

References 

  1. USRDS. United States Renal Data System 2002 Annual Data Report, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2002
  2. Fraser C, Arieff AL. Neurologic complications of chronic renal failure. In:  Schrier RW,  Gottschalk CW editor. Diseases of the kidney. 4th ed. Boston: Little, Brown, and Company; 1988;p. 3063–3092
  3. Walker S, Fine A, Kryger MH. Sleep complaints are common in a dialysis unit. Am J Kidney Dis. 1995;26:751–756
  4. Pressman MR, Benz RL. High incidence of sleep disorders in end stage renal disease. Sleep Research. 1995;24:417
  5. Mendelson WB, Wadhwa NK, Greenberg HE, Gujavarty K, Bergofsky E. Effects of hemodialysis on sleep apnoea syndrome in end-stage renal disease. Clin Nephrol. 1990;33:247–251
  6. Daugirdas J, Blake PG, Ing T. Handbook of Dialysis. Philadelphia: Lippincott Williams & Wilkins; 2001;
  7. Strub B, Schneider-Helmert D, Gnirss F, Blumberg A. [Sleep disorders in patients with chronic renal insufficiency in long-term hemodialysis treatment]. Schweiz Med Wochenschr. 1982;112:824–828
  8. Holley JL, Nespor S, Rault R. Characterizing sleep disorders in chronic hemodialysis patients. ASAIO Trans. 1991;37:M456–M457
  9. Wadhwa NK, Seliger M, Greenberg HE, Bergofsky E, Mendelson WB. Sleep related respiratory disorders in end-stage renal disease patients on peritoneal dialysis. Perit Dial Int. 1992;12:51–56
  10. Hui DS, Wong TY, Ko FW, Li TS, Choy DK, Wong KK. Prevalence of sleep disturbances in Chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 2000;36:783–788
  11. Venmans BJ, van Kralingen KW, Chandi DD, de Vries PM, ter Wee PM, Postmus PE. Sleep complaints and sleep disordered breathing in hemodialysis patients. Neth J Med. 1999;54:207–212
  12. Burmann-Urbanek M, Sanner B, Laschewski F, Kreuzer I, Wiemann J, Konermann M. [Sleep disorders in patients with dialysis-dependent renal failure]. Pneumologie. 1995;49:158–160
  13. Yoshioka M, Ishii T, Fukunishi I. Sleep disturbance of end-stage renal disease. Jpn J Psychiatry Neurol. 1993;47:847–851
  14. Rodriguez MA, Merino D, Grizzo M, Schiavelli R. Sleep disorders in hemodialysis patients. Transplantation Proceedings. 1999;31:3082
  15. Eichel CJ. Stress and coping in patients on CAPD compared to hemodialysis patients. ANNA Journal. 1986;13:9–13
  16. Molzahn AE, Northcott HC, Dossetor JB. Quality of life of individuals with end stage renal disease: perceptions of patients, nurses, and physicians. ANNA J. 1997;24:325–333
  17. Friedrich RM. Patient perception of distress associated with hemodialysis: a state survey. JANNT. 1980;7:252–258
  18. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3:329–338
  19. Parfrey PS, Vavasour HM, Henry S, Bullock M, Gault MH. Clinical features and severity of nonspecific symptoms in dialysis patients. Nephron. 1988;50:121–128
  20. Hart LG, Evans RW. The functional status of ESRD patients as measured by the Sickness Impact Profile. J Chronic Dis. 1987;40:117S–136S
  21. Bass EB, Jenckes MW, Fink NE, Cagney KA, Wu AW, Sadler JH. Use of focus groups to identify concerns about dialysis. Choice Study. Med Decis Making. 1999;19:287–295
  22. Holley JL, Nespor S, Rault R. A comparison of reported sleep disorders in patients on chronic hemodialysis and continuous peritoneal dialysis. Am J Kidney Dis. 1992;19:156–161
  23. Kutner NG, Bliwise DL, Brogan D, Zhang R. Race and restless sleep complaint in older chronic dialysis patients and nondialysis community controls. J Gerontol B Psychol Sci Soc Sci. 2001;56:170–175
  24. Parker K. Dream content and subjective sleep quality in stable patients on chronic dialysis. ANNA J. 1996;23:201–210
  25. Puntriano M. The relationship between dialysis adequacies and sleep problems in hemodialysis patients. Anna J. 1999;26:405–407
  26. Evans RW, Rader B, Manninen DL. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group [see comments]. JAMA. 1990;263:825–830
  27. Virga G, Stanic L, Mastrosimone S, Gastaldon F, da Porto A, Bonadonna A. Hypercalcemia and insomnia in hemodialysis patients. Nephron. 2000;85:94–95
  28. Reichenmiller HE, Reinhard U, Durr F. Sleep EEG and uraemia. Electroencephalogr Clin Neurophysiol. 1971;30:263–264
  29. Passouant P, Cadilhac J, Baldy-Moulinier M, Mion C. [Night sleep in chronic uremics under extrarenal purification]. Electroencephalogr Clin Neurophysiol. 1970;29:441–449
  30. Passouant P, Cadilhac J, Baldy-Moulinier M, Mion C. [Study of nocturnal sleep in chronic uremics subjected to an extrarenal purification]. Rev Neurol (Paris). 1967;117:525
  31. Hallett MD, Burden S, Stewart D, Mahony J, Farrell PC. Sleep apnoea in ESRD patients on HD and CAPD. Perit Dial Int. 1996;16:S429–S433
  32. Parker KP, Bliwise DL, Bailey JL, Rye DB. Daytime sleepiness in stable hemodialysis patients. Am J of Kid Dis. 2003;
  33. Wadhwa NK, Mendelson WB. A comparison of sleep-disordered respiration in ESRD patients receiving hemodialysis and peritoneal dialysis. Adv Perit Dial. 1992;8:195–198
  34. Stepanski E, Faber M, Zorick F, Basner R, Roth T. Sleep disorders in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1995;6:192–197
  35. Hanly PJ, Pierratos A. Improvement of sleep apnoea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med. 2001;344:102–107
  36. Wetter TC, Stiasny K, Kohnen R, Oertel WH, Trenkwalder C. Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome. Mov Disord. 1998;13:820–824
  37. ASDA, The International Classification of Sleep Disorders, Rochester, MN, American Sleep Disorders Association, 1997
  38. Mitra S, Maher C, Mehta P, Kienstra R, Eagleton L. Sleep apnoea in dialysis patients with diabetes. Kidney International. 1983;23:130
  39. Millman RP, Kimmel PL, Shore ET, Wasserstein AG. Sleep apnoea in hemodialysis patients: the lack of testosterone effect on its pathogenesis. Nephron. 1985;40:407–410
  40. Kimmel PL, Miller G, Mendelson WB. Sleep apnoea syndrome in chronic renal disease. Am J Med. 1989;86:308–314
  41. Jean G, Piperno D, Francois B, Charra B. Sleep apnoea incidence in maintenance hemodialysis patients: influence of dialysate buffer. Nephron. 1995;71:138–142
  42. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230–1235
  43. Pfister M, Jakob SM, Marti HP, Frey FJ, Gugger M. Ambulatory nocturnal oximetry and sleep questionnaire- based findings in 38 patients with end-stage renal disease. Nephrol Dial Transplant. 1999;14:1496–1502
  44. Kuhlmann U, Becker HF, Birkhahn M, Peter JH, von Wichert P, Schutterle S. Sleep-apnoea in patients with end-stage renal disease and objective results. Clin Nephrol. 2000;53:460–466
  45. Fein AM, Niederman MS, Imbriano L, Rosen H. Reversal of sleep apnoea in uremia by dialysis. Arch Intern Med. 1987;147:1355–1356
  46. Parker KP, Bliwise DL. Clinical comparison of hemodialysis and sleep apnoea patients with excessive daytime sleepiness. ANNA J. 1997;24:663–665
  47. Kimmel PL, Miller G, Mendelson WB. Sleep apnoea syndrome in chronic renal disease. Am J Med. 1989;86:308–314
  48. Kimmel PL. Sleep disorders in chronic renal disease. Journal of Nephrology. 1989;1:59–65
  49. Fletcher EC. Obstructive sleep apnoea and the kidney [editorial]. J Am Soc Nephrol. 1993;4:1111–1121
  50. Zoccali C. Sleep apnoea and nocturnal hypoxaemia in dialysis patients: mere risk-indicators or causal factors for cardiovascular disease?. Nephrol Dial Transplant. 2000;15:1919–1921
  51. Santiago T, Edelman R, Fishman A. The effects of anemia on the ventilatory response to transient and steady-state hypoxia. Journal of Clinical Investigation. 1975;55:410–418
  52. Soreide E, Skeie B, Kirvela O, Lynn R, Ginsberg N, Manner T. Branched-chain amino acid in chronic renal failure patients: respiratory and sleep effects. Kidney Int. 1991;40:539–543
  53. Pressman MR, Benz RL, Schleifer CR, Peterson DD. Sleep disordered breathing in ESRD: acute beneficial effects of treatment with nasal continuous positive airway pressure. Kidney Int. 1993;43:1134–1139
  54. Auckley DH, Schmidt-Nowara W, Brown LK. Reversal of sleep apnoea hypopnea syndrome in end-stage renal disease after kidney transplantation. Am J Kidney Dis. 1999;34:739–744
  55. Langevin B, Fouque D, Leger P, Robert D. Sleep apnoea syndrome and end-stage renal disease. Cure after renal transplantation. Chest. 1993;103:1330–1335
  56. Benz RL, Pressman MR, Hovick ET, Peterson DD. A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study). Am J Kidney Dis. 1999;34:1089–1095
  57. Janzen L, Rich JA, Vercaigne LM. An overview of levodopa in the management of restless legs syndrome in a dialysis population: pharmacokinetics, clinical trials, and complications of therapy. Ann Pharmacother. 1999;33:86–92
  58. Wetter TC, Trenkwalder C, Stiasny K, Pollmacher T, Kazenwadel J, Kohnen R. [Treatment of idiopathic and uremic restless legs syndrome with L-dopa – a double-blind cross-over study]. Wien Med Wochenschr. 1995;145:518–525
  59. Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis. 1996;28:372–378
  60. Pressman MR, Benz RL, Peterson DD. High incidence of sleep disorders in end-stage renal disease patients. Sleep Research. 1995;24:417A
  61. Trenkwalder C, Stiasny K, Oertel WH. [Therapy of idiopathic and uremic restless legs syndrome]. Nervenarzt. 1996;67:265–276
  62. Walker SL, Fine A, Kryger MH. L-DOPA/carbidopa for nocturnal movement disorders in uremia. Sleep. 1996;19:214–218
  63. Collado-Seidel V, Kohnen R, Samtleben W, Hillebrand GF, Oertel WH, Trenkwalder C. Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis. 1998;31:324–328
  64. Montplaisir J, Nicloas A, Godbout R, Walters A. Restless legs syndrome and periodic limb movement disorder. In:  Kryger MH,  Roth T,  Dement WC editor. Principles and Practice of Sleep Medicine. Philadelphia: W.B. Saunders Company; 2000;p. 742–752
  65. Winkelmann J, Trenkwalder C. [Pathophysiology of restless-legs syndrome. Review of current research]. Nervenarzt. 2001;72:100–107
  66. Rocco MV, Blumenkrantz MJ. Nutrition. In:  Daudridas JT,  Blake PG,  Ing TS editor. Handbook of Dialysis. Philadelphia: Lippincott Williams & Wilkins; 2001;p. 420–445
  67. Furst P. Amino acid metabolism in uremia. J Am Coll Nutr. 1989;8:310–323
  68. Schmid G, Bahner U, Peschkes J, Heidland A. Neurotransmitter and monoaminergic amino acid precursor levels in rat brain: effects of chronic renal failure and of malnutrition. Miner Electrolyte Metab. 1996;22:113–115
  69. Ksiazek A. Brain serotonin and catecholamine turnover in uremic rats. Nephron. 1982;31:270–272
  70. Levine AS, Morley JE, Raij L. Opiates and the anorexia of uremia. Physiol Behav. 1986;37:835–838
  71. Sandyk R, Bernick C, Lee SM, Stern LZ, Iacono RP, Bamford CR. L-dopa in uremic patients with the restless legs syndrome. Int J Neurosci. 1987;35:233–234
  72. Trenkwalder C, Stiasny K, Pollmacher T, Wetter T, Schwarz J, Kohnen R. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep. 1995;18:681–688
  73. Pieta J, Millar T, Zacharias J, Fine A, Kryger M. Effect of pergolide on restless legs and leg movements in sleep in uremic patients. Sleep. 1998;21:617–622
  74. Winkelmann J, Wetter TC, Stiasny K, Oertel WH, Trenkwalder C. Treatment of restless leg syndrome with pergolide – an open clinical trial. Mov Disord. 1998;13:566–569
  75. Braude W, Barnes T. Clonazepam: effective treatment for restless legs syndrome in uraemia. Br Med J (Clin Res Ed). 1982;284:510
  76. Cavatorta F, Vagge R, Solari P, Queirolo C. [Preliminary results with clonidine in the restless legs syndrome in 2 hemodialyzed uremic patients]. Minerva Urol Nefrol. 1987;39:93
  77. Yasuda T, Nishimura A, Katsuki Y, Tsuji Y. Restless legs syndrome treated successfully by kidney transplantation – a case report. Clin Transpl. 1986;138
  78. Schreiner GE. Mental and personality changes in the uremic syndrome. Medical Annals of the District of Columbia. 1959;28:127–133
  79. Chervin RD, Aldrich MS. The Epworth Sleepiness Scale may not reflect objective measures of sleepiness or sleep apnoea. Neurology. 1999;52:125–131
  80. Dinges DF, Pack F, Williams K, Gillen KA, Powell JW, Ott GE. Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4–5 hours per night. Sleep. 1997;20:267–267
  81. Doghramji K, Mitler MM, Sangal RB, Shapiro C, Taylor S, Walsleben J. A normative study of the Maintenance of Wakefulness Test (MWT). Electroencephalogr Clin Neurophysiol. 1997;103:554–562
  82. Berry RB, Gleeson K. Respiratory arousal from sleep: mechanisms and significance. Sleep. 1997;20:654–675
  83. MacFarlane JG, Shahal B, Mously C, Moldofsky H. Periodic K-alpha sleep EEG activity and periodic limb movements during sleep: comparisons of clinical features and sleep parameters. Sleep. 1996;19:200–204
  84. Mendelson WB. Are periodic leg movements associated with clinical sleep disturbance?. Sleep. 1996;19:219–223
  85. Adams N, Strauss M, Schluchter M, Redline S. Relation of measures of sleep-disordered breathing to neuropsychological functioning. Am J Respir Crit Care Med. 2001;163:1626–1631
  86. Teschan PE, Bourne JR, Reed RB, Ward JW. Electrophysiological and neurobehavioral responses to therapy: the National Cooperative Dialysis Study. Kidney Int Suppl. 1983;S58–S65
  87. Balzer S, Kuttner K. [Early auditory evoked potential. A diagnostic parameter in uremic encephalopathy]. Hno. 1996;44:559–566
  88. Hamel B, Bourne JR, Ward JW, Teschan PE. Visually evoked cortical potentials in renal failure: transient potentials. Electroencephalogr Clin Neurophysiol. 1978;44:606–616
  89. Bro S, Olgaard K. Effects of excess PTH on nonclassical target organs. Am J Kidney Dis. 1997;30:606–620
  90. Guisado R, Arieff AI, Massry SG, Lazarowitz V, Kerian A. Changes in the electroencephalogram in acute uremia. Effects of parathyroid hormone and brain electrolytes. J Clin Invest. 1975;55:738–745
  91. Goldstein DA, Feinstein EI, Chui LA, Pattabhiraman R, Massry SG. The relationship between the abnormalities in electroencephalogram and blood levels of parathyroid hormone in dialysis patients. J Clin Endocrinol Metab. 1980;51:130–134
  92. De Deyn PP, Macdonald RL. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture [see comments]. Ann Neurol. 1990;28:627–633
  93. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 2000;35:644–652
  94. Rousseau Y, Haeffner-Cavaillon N, Poignet JL, Meyrier A, Carreno MP. In vivo intracellular cytokine production by leukocytes during haemodialysis. Cytokine. 2000;12:506–517
  95. Plum F, Posner JB. Multifocal, diffuse, and metabolic brain diseases causing stupor or come. In:  Plum FP,  Posner JB editor. The Diagnosis of Stupor and Coma. Philadelphia: F.A. Davis; 1985;p. 177–303
  96. Moldofsky H, Krueger JM, Walter J, Dinarello CA, Lue FA, Quance G. Sleep-promoting material extracted from peritoneal dialysate of patients with end-stage renal disease and insomnia. Peritoneal Dialysis Bulletin. 1985;189–193
  97. Vaziri ND, Oveisi F, Reyes GA, Zhou XJ. Dysregulation of melatonin metabolism in chronic renal insufficiency: role of erythropoietin-deficiency anemia. Kidney Int. 1996;50:653–656
  98. Parker K, Bliwise D, Rye D. Hemodialysis disrupts basic sleep regulation: Hypothesis building. Nursing Research. 2000;49:327–332
  99. Hart LG, Evans RW. The functional status of ESRD patients as measured by the Sickness Impact Profile. J Chronic Dis. 1987;40:117S–136S
  100. Devins GM, Edworthy SM, Paul LC, Mandin H, Seland TP, Klein G. Restless sleep, illness intrusiveness, and depressive symptoms in three chronic illness conditions: rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Psychosom Res. 1993;37:163–170
  101. Daley RJ, Hassall C. Reported sleep maintenance on haemodialysis. British Medical Journal. 1970;2:508–509
  102. Sweatman AJ, Baillod RA, Moorhead JF. Comparison of home dialysis and other treatments for chronic renal failure. The Practitioner. 1974;212:56–66
  103. Daly RJ, Hassall C. Reported sleep on maintenance haemodialysis. Br Med J. 1970;2:508–509
  104. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S. Association of sleep-disordered breathing, sleep apnoea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000;283:1829–1836
  105. Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol. 2001;154:50–59
  106. Portaluppi F, Montanari L, Massari M, Di Chiara V, Capanna M. Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. Am J Hypertens. 1991;4:20–26
  107. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA. Autonomic neuropathy is linked to nocturnal hypoxaemia and to concentric hypertrophy and remodeling in dialysis patients. Nephrol Dial Transplant. 2001;16:70–77
  108. Benz RL, Pressman MR, Hovick ET, Peterson DD. Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders [see comments]. Am J Kidney Dis. 2000;35:1052–1060

PII: S1087-0792(01)90240-0

doi: 10.1053/smrv.2001.0240

Sleep Medicine Reviews
Volume 7, Issue 2 , Pages 131-143 , April 2003

Article Tools